U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue -- -- -- 600.00 7.50K
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- 600.00 7.50K
Cost of Revenue -- -- -- 50.00K 134.40K
Gross Profit -- -- -- -49.40K -126.90K
SG&A Expenses 1.30M 1.32M 1.15M 1.30M 1.04M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.13M 2.43M 2.42M 3.24M 2.36M
Operating Income -2.13M -2.43M -2.42M -3.24M -2.35M
Income Before Tax -2.26M -1.39M -1.48M -3.48M -5.71M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -2.26M -1.39M -1.48M -3.48M -5.71M
Earnings from Discontinued Operations -- 7.43M -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 0.00 -- 0.00 0.00 --
Net Income -2.26M 6.03M -1.48M -3.48M -5.71M
EBIT -2.13M -2.43M -2.42M -3.24M -2.35M
EBITDA -2.10M -2.40M -2.39M -3.22M -2.33M
EPS Basic -0.02 0.12 -0.05 -0.11 -0.25
Normalized Basic EPS -0.01 -0.04 -0.03 -0.05 -0.05
EPS Diluted -0.02 0.12 -0.05 -0.11 -0.25
Normalized Diluted EPS -0.01 -0.04 -0.03 -0.05 -0.05
Average Basic Shares Outstanding 99.36M 48.24M 32.65M 32.38M 30.73M
Average Diluted Shares Outstanding 99.36M 48.24M 32.65M 32.38M 30.73M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings